Hikma Pharmaceutical | HIK - Spese Operative

Prezzo Delle Azioni
1,229.00
Cambio Giornaliero
-20.00 -1.60%
Mensile
-20.19%
Annuale
-43.21%
Q1 Previsione
1,287.59




Spese Operative Cambiamento Data
Almirall EUR 517.4M 32K 2025-12
argenx SE USD 914.57M 137.58M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Autolus Therapeutics Ltd USD 82.61M 8.39M 2025-06
Bayer EUR 10.33B 126M 2025-12
Fresenius EUR 5.25B 337M 2025-12
Galapagos EUR 120.26M 7.43M 2025-12
Genmab DKK 565M 38M 2025-06
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
GRIFOLS EUR 1.71B 193M 2025-12
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lonza CHF 3.09B 564M 2024-12
Merck EUR 4.11B 117M 2025-09
Orion EUR 367.1M 64.9M 2025-12
Recordati EUR 384.01M 82.67M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 10.51B 1.21B 2025-12
UCB EUR 2.36B 108M 2024-12